PMV Pharmaceuticals (PMVP) Amortizatization of Intangibles (2019 - 2026)

PMV Pharmaceuticals (PMVP) has 8 years of Amortizatization of Intangibles data on file, last reported at $385000.0 in Q1 2026.

• Quarterly Amortizatization of Intangibles fell 54.17% year-over-year to $385000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (down 49.47% YoY) and the FY2025 annual result came in at $2.8 million, down 48.41% from the prior year.
• Amortizatization of Intangibles fell to $385000.0 in Q1 2026, from $513000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $1.9 million in Q4 2023 to a low of -$72000.0 in Q2 2022.
• A 5-year average of $855352.9 and a median of $724000.0 in 2025 frame the typical range for Amortizatization of Intangibles.
• Annual changes were most pronounced in 2023 — Amortizatization of Intangibles jumped 1429.17% — and 2025, when it sank 54.68%.
• Tracing PMVP's Amortizatization of Intangibles over 5 years: stood at $526000.0 in 2022, then soared by 256.46% to $1.9 million in 2023, then tumbled by 39.63% to $1.1 million in 2024, then slumped by 54.68% to $513000.0 in 2025, then declined by 24.95% to $385000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $385000.0 (Q1 2026), $513000.0 (Q4 2025), and $694000.0 (Q3 2025), per Business Quant data.